# Screening Expiratory Flow Limitation by Flow-time Curve

> **NCT03215316** · — · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 45 (actual)

## Conditions studied

- ARDS, Human

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03215316
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2024-08-12
- **Final completion:** 2024-08-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03215316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03215316, "Screening Expiratory Flow Limitation by Flow-time Curve". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03215316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*